![](/wp-content/uploads/2018/10/OCgj31J9SHGe7UDOhktp.png)
$599
New Ph1 LY900027 RAI Compound Could Be For Closed Loop
A Ph1 trial for a new Lilly compound (LY900027) has been observed on CT.gov. Below, FENIX provides thoughts on what the potential MOA could be particularly given the similarity in compound ID with Lilly’s ultra-rapid-acting insulin lispro (URLi), LY900014.